Cargando…

Prognostic factors for conversion to generalization in ocular myasthenia gravis

Patients with ocular myasthenia gravis (OMG) are frequently treated to prevent the development of generalized myasthenia gravis (GMG). This retrospective cohort study aimed to assess prognostic factors associated with conversion to GMG. We analyzed the time from the onset of OMG symptoms to GMG in r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Witthayaweerasak, Juthamat, Rattanalert, Narisa, Aui-aree, Nipat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	5300
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133228/ https://www.ncbi.nlm.nih.gov/pubmed/34106649 http://dx.doi.org/10.1097/MD.0000000000025899

Ejemplares similares

Clinical Prediction Score for Early Neuroimaging in Acquired Isolated Oculomotor Nerve Palsy
por: Witthayaweerasak, Juthamat, et al.
Publicado: (2020)

Correlation between relative afferent pupillary defect and visual field defects on Humphrey automated perimetry: A cross-sectional clinical trial
por: Witthayaweerasak, Juthamat, et al.
Publicado: (2022)

Newly diagnosed multiple sclerosis in a patient with ocular myasthenia gravis: A case report
por: Bong, Jeong Bin, et al.
Publicado: (2022)

Low serum albumin concentrations are associated with disease severity in patients with myasthenia gravis
por: Weng, Yi-Yun, et al.
Publicado: (2016)

Facial-onset sensory and motor neuronopathy with myasthenia gravis: A case report
por: Pan, Chengyu, et al.
Publicado: (2023)

Initial Repetitive Nerve Stimulation Test Predicts Conversion of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis
por: Kim, Ki Hoon, et al.
Publicado: (2021)

TNFAIP3 gene rs7749323 polymorphism is associated with late onset myasthenia gravis
por: Yang, Hong-Wei, et al.
Publicado: (2017)

Traditional Chinese medicine for myasthenia gravis: Study protocol for a network meta-analysis
por: Xie, Rongfang, et al.
Publicado: (2020)

Guillain-Barré syndrome associated with myasthenia gravis: Three cases report and a literature review
por: Cao, Yayun, et al.
Publicado: (2019)

Global research hotspots and frontiers of myasthenia gravis from 2002 to 2021: A bibliometric study
por: Yang, Jiali, et al.
Publicado: (2023)

Efficacy and safety of double-filtration plasmapheresis treatment of myasthenia gravis: A systematic review and meta-analysis
por: Liu, Chaoying, et al.
Publicado: (2021)

Higher Risk of Myasthenia Gravis in Patients With Thyroid and Allergic Diseases: A National Population-Based Study
por: Yeh, Jiann-Horng, et al.
Publicado: (2015)

New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: A case report and literature review
por: Takizawa, Tsubasa, et al.
Publicado: (2017)

Comparative the efficacy and acceptability of immunosuppressive agents for myasthenia gravis: A protocol for systematic review and network meta-analysis
por: Xu, Peng, et al.
Publicado: (2022)

Clinical features and outcomes of Myasthenia Gravis associated with COVID-19 vaccines: A systematic review and pooled analysis
por: Tayebi, Amir Hossein, et al.
Publicado: (2023)

Tonifying spleen and replenishing kidney method of traditional Chinese medicine for myasthenia gravis: A protocol for systematic review and meta-analysis
por: Lu, Bibo, et al.
Publicado: (2021)

Dynamic nomogram for predicting generalized conversion in adult-onset ocular myasthenia gravis
por: Bi, Zhuajin, et al.
Publicado: (2022)

Effectiveness and safety of thymectomy plus prednisone compares with prednisone monotherapy for the treatment of non-thymomatous Myasthenia Gravis: Protocol for a systematic review
por: Yang, Huili, et al.
Publicado: (2020)

Treatment of myasthenia gravis with the method of tonifying spleen and replenishing qi in traditional Chinese medicine: A protocol for systematic review and meta-analysis
por: Jiang, Li, et al.
Publicado: (2022)

Comparison of Clinical Manifestations between Patients with Ocular Myasthenia Gravis and Generalized Myasthenia Gravis
por: Roh, Hyun Seok, et al.
Publicado: (2011)

Sotalol‐induced generalized and ocular myasthenia gravis
por: Sharifkazemi, Mohammadbagher, et al.
Publicado: (2019)

Invigorating spleen, replenishing qi and tonifying kidney method treatment of traditional Chinese medicine for myasthenia gravis: A protocol for systematic review and meta-analysis
por: Liu, Miao, et al.
Publicado: (2022)

Coexisting myasthenia gravis, myositis, and polyneuropathy induced by ipilimumab and nivolumab in a patient with non-small-cell lung cancer: A case report and literature review
por: Chen, Jia-Hung, et al.
Publicado: (2017)

Controversies in Ocular Myasthenia Gravis
por: Evoli, Amelia, et al.
Publicado: (2020)

Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
por: Townsel, Courtney, et al.
Publicado: (2016)

Ocular myasthenia gravis: A review
por: Nair, Akshay Gopinathan, et al.
Publicado: (2014)

Update on ocular myasthenia gravis in Taiwan
por: Lin, Chao-Wen, et al.
Publicado: (2018)

Human Leucocyte Antigen B50 Is Associated with Conversion to Generalized Myasthenia Gravis in Patients with Pure Ocular Onset
por: Tiftikcioglu, Bedile Irem, et al.
Publicado: (2017)

Frontalis sling procedure for ocular myasthenia gravis
por: Asamura, Shinichi, et al.
Publicado: (2012)

Ocular myasthenia gravis in a setting of thyrotoxicosis
por: Chhabra, Sarabjeet, et al.
Publicado: (2013)

Autoantibodies in Japanese patients with ocular myasthenia gravis
por: Nagaishi, Akiko, et al.
Publicado: (2020)

Commentary: Ocular myasthenia gravis: Interpreting the investigations
por: Nair, Akshay Gopinathan
Publicado: (2022)

Ocular Myasthenia Gravis: A Current Overview
por: Behbehani, Raed
Publicado: (2023)

Ophthalmologic clinical features of ocular myasthenia gravis
por: Kim, Do-Hyung, et al.
Publicado: (2023)

Thymectomy in ocular myasthenia gravis—prognosis and risk factors analysis
por: Zhang, Jinwei, et al.
Publicado: (2022)

A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone
por: Bhagavan, Sachin M., et al.
Publicado: (2021)

Prediction of generalization of ocular myasthenia gravis under immunosuppressive therapy in Northwest China
por: Ding, Jiaqi, et al.
Publicado: (2020)

Development and Validation of a Nomogram for Predicting Generalization in Patients With Ocular Myasthenia Gravis
por: Ruan, Zhe, et al.
Publicado: (2022)

Risk Factors for Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study
por: Guo, Rong-Jing, et al.
Publicado: (2021)

Diagnostic yields and clinical features of ocular myasthenia gravis
por: Kim, Hyuna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l6b8k82h0sonmrpkienol7f90a